US Eyes 7.5% China Tariff Cut — Six Indian Exporters Whose Filing-Backed Advantage Could Vanish
The US is reportedly weighing a reduction in tariffs on Chinese goods to 7.5%, ahead of the Xi-Trump summit scheduled for September 24 at the White House. At first glance, this looks like a US-China story. But for Indian investors, the second-order implications are significant — and the Commerce Ministry seems to know it.
On September 1, the Commerce Ministry has called an urgent meeting with industry associations and exporters specifically to discuss India-US trade. The timing is no coincidence. India locked in tariff rates of approximately 18% under its trade deal with the US earlier this year. If China secures a 7.5% rate, Indian exports would suddenly face tariffs more than double those on competing Chinese goods.
We searched through company filings on Xaro to find the exporters whose own management explicitly cited India's tariff advantage over China as a competitive edge. These are the companies with the most to lose if that edge disappears.
PCBL Chemical — The Tariff Advantage Is a Core Thesis
PCBL, India's largest carbon black manufacturer, laid out its investment case in stark terms during its Q1 FY27 earnings call in July 2026. Management identified three "structural shifts" underpinning their growth story: India's expanding trade agreements, "our tariff advantage in the U.S. market," and the contraction in Russian carbon black exports.
The US currently accounts for around 5% of PCBL's volume, constrained by a 50% tariff on Indian carbon black. Management noted that "as US continues to be import-dependent for carbon black, we expect both volume and margin to recover once the situation stabilizes." But if China enters the US market at 7.5% while India remains at a higher rate, PCBL's "tariff advantage" thesis flips entirely. The global tyre industry's manufacturing shift toward India — another tailwind management cited — could slow if Chinese carbon black regains cost competitiveness in the US.
Gokaldas Exports — The China Hedge That Could Unwind
Gokaldas Exports, one of India's largest garment exporters, has been a direct beneficiary of the trade war. In its FY25 earnings call, management noted that "higher tariff on China and political uncertainties in Bangladesh contribute to overall attractiveness of the country as a sourcing destination." The India-UK FTA gave them an additional 12% duty advantage over China.
The numbers backed up the thesis: FY25 total income grew 19% (versus 10% for Indian exports overall), EBITDA hit Rs 424 crore (up 49%), and Q4 FY25 delivered revenue of Rs 1,035 crore at a 13.7% EBITDA margin. But FY26 was already impacted by US reciprocal tariffs, and management guided that FY27 margins should improve — contingent on the tariff environment stabilizing. A 7.5% China rate would destabilize it further. Winter-season synthetic garments, which management acknowledged are "product mainstays of China, Vietnam, Cambodia," would become cheaper for US buyers to source from Chinese factories again.
Indo Count Industries — Recovery Hinges on the Tariff Gap
Indo Count, a leading bed linen and home textile exporter, is in the early stages of recovery after a tariff-hit FY26. Management told investors that the India-US trade deal is "creating a more favorable and level playing field for Indian textile exporters" and is "expected to accelerate the shift in global sourcing towards India."
Q1 FY27 volumes reached 23 million meters, up from 20.5 million meters in Q4 FY26 — a meaningful sequential recovery. But that recovery is priced around the assumption that India has a level playing field. If China gets a 7.5% tariff while India sits at 18%, the field tilts sharply against Indian home textile producers. Indo Count management acknowledged as much when asked about FY27 margin outlook, saying it depends on tariffs normalizing "around 15% to 20%."
Aarti Industries — Absorbing Tariffs, Banking on the Deal
Aarti Industries, one of India's largest specialty chemical manufacturers, reported Q3 FY26 revenue of Rs 2,492 crore. The company disclosed that it has been partially absorbing US tariff costs on key products like MMA (methyl methacrylate) and PDCB (paradichlorobenzene), with "upside possible in margins" once the trade deal benefits flow through.
With 43% of revenue coming from agrochemicals — a category where intermediates flow through complex global supply chains before reaching US end-markets — Aarti's exposure is indirect but real. Management expects the US-India trade deal to restore volume growth, but if Chinese specialty chemicals enter the US at less than half India's tariff rate, downstream customers may redirect procurement. Aarti noted that the "tariff itself could have an impact on the overall demand profile within the U.S. market."
Rolex Rings — New Business Won on Tariff Math
Rolex Rings, a forged and machined rings maker for bearings and auto components, offers perhaps the clearest before-and-after picture. Exports account for 43% of revenue, with the US as a key market. Management disclosed that US import duties on Indian goods were 53% as recently as October 2025, during which "most importers took a stand to just keep on hold their imports from India."
After the India-US trade deal brought duties down to 18%, orders resumed. Management reported a Rs 60 crore annualized new business nomination won in the weeks after the deal, and guided for roughly Rs 1,150 crore in topline for the fiscal year. But that new business was won on the math of 18% Indian duty versus much higher Chinese duty. If China secures 7.5%, that math breaks — Chinese forging competitors would enjoy a tariff rate less than half of India's.
Faze Three — They Saw It Coming
Faze Three, a home textiles exporter specializing in bath mats, rugs, and floor coverings, may have the most prescient filing disclosure. In their investor presentation, the company explicitly listed "Cost & tariff arbitrage neutralised between India & China" as a competitive risk under their home textiles segment.
Unlike other companies that built their bull case on the tariff gap, Faze Three's management acknowledged the fragility of that advantage. If the US-China summit delivers a 7.5% tariff, Faze Three's filing will read like a warning that the rest of the market ignored.
What Retail Investors Should Do
The September 24 summit is still weeks away, and tariff negotiations are unpredictable. But the risk is asymmetric: markets have priced in India's post-deal export recovery, and few investors are pricing in a scenario where China gets a better rate than India.
Investors holding export-heavy stocks — particularly in textiles, specialty chemicals, and auto components — should review their portfolio companies' most recent earnings calls for specific tariff exposure disclosures. The companies above are not necessarily sells, but they are the ones whose stated competitive advantages are most directly tied to a tariff differential that could narrow or reverse. Watch the Commerce Ministry's September 1 meeting for signals on whether India will seek to renegotiate its own deal terms.
Data sourced from company filings on NSE via Xaro.